statistiche ricercatore

Continente	#
NA - Nord America	2.136
EU - Europa	1.336
AS - Asia	926
Continente sconosciuto - Info sul continente non disponibili	251
SA - Sud America	125
AF - Africa	22
OC - Oceania	1
Totale	4.797

Nazione	#
US - Stati Uniti d'America	2.049
IT - Italia	461
SG - Singapore	310
DE - Germania	226
CN - Cina	218
RU - Federazione Russa	144
VN - Vietnam	130
HK - Hong Kong	108
BR - Brasile	101
CA - Canada	74
GB - Regno Unito	73
SE - Svezia	69
IE - Irlanda	63
FI - Finlandia	58
FR - Francia	52
DK - Danimarca	49
PL - Polonia	40
IN - India	36
AT - Austria	24
ID - Indonesia	20
TR - Turchia	19
UA - Ucraina	19
BD - Bangladesh	15
ES - Italia	13
NL - Olanda	13
JP - Giappone	10
AR - Argentina	9
BE - Belgio	9
IQ - Iraq	9
KR - Corea	9
MX - Messico	9
SA - Arabia Saudita	9
ZA - Sudafrica	7
CZ - Repubblica Ceca	5
AE - Emirati Arabi Uniti	4
CL - Cile	4
PK - Pakistan	4
VE - Venezuela	4
CH - Svizzera	3
HU - Ungheria	3
IR - Iran	3
LT - Lituania	3
MA - Marocco	3
PS - Palestinian Territory	3
UZ - Uzbekistan	3
EC - Ecuador	2
EG - Egitto	2
JM - Giamaica	2
KE - Kenya	2
KG - Kirghizistan	2
LB - Libano	2
MY - Malesia	2
PE - Perù	2
PH - Filippine	2
PT - Portogallo	2
TW - Taiwan	2
UY - Uruguay	2
AL - Albania	1
AU - Australia	1
BH - Bahrain	1
BW - Botswana	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
ET - Etiopia	1
GA - Gabon	1
HR - Croazia	1
JO - Giordania	1
KH - Cambogia	1
LU - Lussemburgo	1
LV - Lettonia	1
MN - Mongolia	1
MU - Mauritius	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TH - Thailandia	1
TN - Tunisia	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	4.547

Nome	#
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	695
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells	539
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3)	507
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.	477
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis	475
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation	465
FR051, a novel Hexosamine Biosynthetic Pathway inhibitor, induces cell death in breast and pancreatic cancer models.	397
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability	372
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor	348
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells	346
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	176
Totale	4.797

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	255	0	40	32	39	24	29	12	10	9	15	19	26
2022/2023	309	43	92	43	38	14	41	3	12	11	2	8	2
2023/2024	198	3	11	7	13	15	52	50	16	7	3	0	21
2024/2025	753	37	36	77	19	38	45	86	66	82	119	54	94
2025/2026	1.407	148	76	107	155	214	78	217	45	102	105	67	93
2026/2027	44	39	5	0	0	0	0	0	0	0	0	0	0
Totale													4.797

Bicocca Open Archive